Navigation Links
Insurance, Income Don't Explain 'Race Gap' in Breast Cancer Care
Date:10/12/2010

By Kathleen Doheny
HealthDay Reporter

TUESDAY, Oct. 12 (HealthDay News) -- The so-called racial gap in breast cancer care has long been known by researchers, with black and Hispanic women less likely to get recommended breast cancer treatments than white patients.

"Less well known is what the issue is -- is it race itself or something else contributing?" said Dr. Rachel Freedman, a medical oncologist at Dana Farber Cancer Institute in Boston, and an instructor in medicine at Harvard Medical School.

Her team's new study suggests that financial factors such as economic and social class or access to insurance alone can't explain the "gap": Even after accounting for those differences, racial disparities in breast cancer care still showed up.

The study, published online Oct. 11 in the journal Cancer, "was unique because it included adult women of all ages, and included [those with] insurance," Freedman said.

Freedman evaluated information on more than 662,000 white, black and Hispanic women diagnosed with invasive breast cancer from 1998 to 2005. She used data from the U.S. National Cancer Data Base, a registry that collects information on patients' treatments, outcomes, insurance and socioeconomic status.

In the database, 86 percent of the women were white, 10 percent black, and 4 percent Hispanic.

When they evaluated whether women got the correct treatments and testing, the team found no differences by race/ethnicity for hormone receptor testing (evaluating whether a cancer is estrogen-receptor positive or negative, which could help guide treatment).

But they did find differences in other interventions. For example, black women had lower odds of getting recommended treatments -- interventions such as mastectomy or breast-conserving therapy, chemotherapy and hormone therapy (such as aromatase inhibitor drugs to reduce recurrence risk), Freedman said. And Hispanic women were less likely than white women to get hormonal therapy.

Freedman found black women 9 percent less likely than white women to get mastectomy, breast-conserving surgery or other treatments, 10 percent less likely to get hormonal therapy and 13 percent less likely to get chemotherapy.

Importantly, these disparities persisted even after the researchers accounted for insurance coverage and socioeconomic status. "In this study, even with those with the same insurance, there were race gaps," Freedman said.

"Further investigation is needed," she said, "to figure out which [other] factors are meaningful."

Freedman said the study does have limitations, including her finding of relatively modest absolute differences in the care different types of patients received. Even so, because breast cancer is so often diagnosed, these small discrepancies would end up affecting large numbers of women, she said.

While the database was large, the information was not always complete. Information was missing on many women. For instance, more than 46,000 women were excluded from the chemotherapy analysis, because data was missing.

One expert agreed that a gap in care linked to race does seem to persist.

Despite the study's limitations, "it does look like there still are racial differences, but tempered somewhat by insurance and socioeconomic status," said Dr. Nina Bickell, associate professor of healthy policy and medicine, Mount Sinai School of Medicine in New York City.

But for women of any race diagnosed with breast cancer, the message is the same, said Bickell. "I would tell anybody they should be getting information, and there's lots of excellent information available to those with breast cancer."

"Get it from credible sources," she said, such as the American Cancer Society.

She also recommends that women diagnosed with breast cancer write a list of questions before they go in for a doctor visit, take a friend or family member with them to help them understand options, and consider taking a tape recorder so information can be replayed later.

More information

To find out more about race-linked discrepancies in cancer care, head to standuptocancer.org.

SOURCES: Rachel A. Freedman, M.D., M.P.H., medical oncologist, Dana Farber Cancer Institute, Boston; Nina Bickell, M.D., M.P.H., associate professor, health policy and medicine, Mount Sinai School of Medicine, New York City; Oct. 11, 2010, Cancer, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Midlife crisis: Unmarried older women twice as likely to lack health insurance, study shows
2. Labiaplasty May Be Covered by Insurance, Notes Chicago-area Plastic Surgeon Allan Parungao, MD
3. Uninsured more likely to die from trauma than patients with insurance, study finds
4. Insurance, Race and Poverty Affect Cancer Care, Researchers Report
5. Obese workers cost workplace more than insurance, absenteeism
6. PA Breast Cancer Coalition Launches Income Tax Refund Campaign
7. Guardian Brings Income Protection to New Level with Student Loan Protection Program
8. Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results
9. Unilens Vision Reports Record Second Quarter Earnings And Royalty Income
10. K-State Study Finds Abundance of Food Stores, Not Lack of Them, Puts Low-Income Women In Small Cities at Higher Risk of Obesity
11. Study: Kidney disease a big risk for younger, low-income minorities
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Insurance, Income Don't Explain 'Race Gap' in Breast Cancer Care
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is ... leading bottled water brand owners that topped the list as a result of their ... conversion. The premier brand was Tibet 5100, a top notch water company that specializes ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... Diego, will bring together more than 200 of the country’s top healthcare executives ... future. , “The true benefit of the Forum is the provider-centric perspective, experience, ...
(Date:2/10/2016)... ... , ... Armune BioScience signed a definitive agreement with ARCpoint ... across the country. Launched in April of 2015, Apifiny is the only cancer specific, ... order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized ...
(Date:2/10/2016)... ... February 10, 2016 , ... A national ... Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau of Worker's ... , As the longest running and largest worker's compensation event in Ohio, organizers ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... February 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | ... | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and SAN DIEGO , ... Inc., a global leader in viral gene therapy manufacturing, ... treatments for congestive heart failure and other chronic diseases, ... a scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) ... --> --> ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
Breaking Medicine Technology: